Lenacapavir Manufacturing In SA: Strengthening Production
Lenacapavir manufacturing in SA aims to strengthen supply chains and provide critical HIV prevention solutions.
Human HIV Vaccine Trial Begins With BRILLIANT 011
South Africa launches the HIV vaccine trial, BRILLIANT 01, testing a new vaccine cocktail designed to prime broadly neutralising antibodies.
2026 Healthcare Watchlist: Nine Healthcare Stories to Track
Spotlight’s 2026 Healthcare Watchlist highlights nine health topics, from a new HIV prevention jab to NHI court battles and aid shocks.
HIV Prevention in SA Needs Local Lenacapavir Manufacturing
HIV prevention in South Africa hinges on local drug manufacturing to ensure access, reduce delays, and enable regional health security.
Lenacapavir in Short Supply Amid HIV Epidemic in Africa
Explore the controversy surrounding Lenacapavir in short supply in Africa and the impact on HIV prevention efforts.
China’s HIV Prevention Funding Targets Vulnerable Youth
China's HIV prevention funding of $3.49 million aims to support South Africa's young people and drug users for better health outcomes.
Sakeliga’s NHI Legal Battle for Constiutional Justice
Learn about Sakeliga's NHI legal battle as they challenge the constitutionality of South Africa's National Health Insurance plan.
Lenacapavir for HIV Prevention in South Africa
South Africa will introduce lenacapavir for HIV prevention in 2026, offering a new hope in the fight against HIV.
HIV/AIDS Funding Gap: Government Steps In
The South African government has stepped in with a crucial R753.5 million injection from the National Treasury to sustain the nation’s HIV/Aids programmes. This vital funding seeks to close the HIV/AIDS funding gap. The withdrawal of the United States President’s Emergency Plan for AIDS Relief (PEPFAR) significantly impacted this gap. This move had threatened to…...
Child HIV Treatment and Access to Care
Learn about the state of child HIV treatment in South Africa and the critical gaps in access to essential antiretroviral therapy.